Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in patients with non-Hodgkin's lymphoma in the United Kingdom (UK)

Whyte, S, Cooper, KL, Stevenson, MD and Akehurst, R (2011) Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in patients with non-Hodgkin's lymphoma in the United Kingdom (UK). Discussion Paper. HEDS Discussion Paper (11-02). (Unpublished)

Abstract

Metadata

Authors/Creators:
  • Whyte, S (sophie.whyte@sheffield.ac.uk)
  • Cooper, KL (k.l.cooper@sheffield.ac.uk)
  • Stevenson, MD (m.d.stevenson@sheffield.ac.uk)
  • Akehurst, R (r.l.akehurst@sheffield.ac.uk)
Keywords: cost-effectiveness; economic model; febrile neutropenia; granulocyte colony–stimulating factors; prophylaxis; non-Hodgkin’s lymphoma
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Health Economics and Decision Science > HEDS Discussion Paper Series
Depositing User: ScHARR / HEDS (Sheffield)
Date Deposited: 05 Apr 2011 11:44
Last Modified: 06 Jun 2014 00:50
Status: Unpublished

Download

Filename: HEDS_DP_11-02.pdf

Share / Export